116 related articles for article (PubMed ID: 2214181)
21. [Clinical studies of natural interferon alpha (HLBI) in chronic myelogenous leukemia--a multi-institutional cooperative study in Japan].
Koyama S; Moriyama Y; Shibata A; Miura Y; Abe T; Asano S; Miyazaki T; Miura A; Kariyone S; Toyama K
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2959-66. PubMed ID: 3052301
[TBL] [Abstract][Full Text] [Related]
22. Successful one antigen mismatched bone marrow transplant for chronic myeloid leukemia (CML) after two failed syngeneic transplants.
Manna A; Bacigalupo A; Palazzo G; Amurri B; Maggi A; Mazza P
Bone Marrow Transplant; 1999 May; 23(10):1085-6. PubMed ID: 10373077
[TBL] [Abstract][Full Text] [Related]
23. [A case of chronic myeloid leukemia with cytogenetic remission and disappearance of Ph1 positive cells due to interferon-alpha administration].
Yoshida M; Fujiwara Y; Yoshinaga H; Maeda T; Mori Y; Nonaka K; Senoo K; Atsui F
Nihon Naika Gakkai Zasshi; 1991 May; 80(5):766-7. PubMed ID: 1875114
[No Abstract] [Full Text] [Related]
24. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
Nese M; de Bellis R; Urtiarte R; Di Landro J
Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
[TBL] [Abstract][Full Text] [Related]
26. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
[TBL] [Abstract][Full Text] [Related]
27. [Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment].
Watanabe S; Sugihara T; Takahashi M; Ata K; Kanzaki A; Yamada O; Yawata Y
Rinsho Ketsueki; 1994 Sep; 35(9):895-7. PubMed ID: 7967060
[TBL] [Abstract][Full Text] [Related]
28. Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia.
Ghanima W; Kahrs J; Dahl TG; Tjonnfjord GE
Eur J Haematol; 2004 Jun; 72(6):441-3. PubMed ID: 15128424
[TBL] [Abstract][Full Text] [Related]
29. [A case of chronic neutrophilic leukemia with abnormal karyotype].
Kunishima S; Mizuno R; Fujishiro N; Ohno R
Rinsho Byori; 1989 Aug; 37(8):943-7. PubMed ID: 2585758
[TBL] [Abstract][Full Text] [Related]
30. [Reversible cardiomyopathy secondary to interferon-alpha in chronic myelogenous leukemia].
Uehara E; Uesugi T; Tasaka T; Matsuhashi Y; Tamura T; Kuwajima M; Nagai M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):317-21. PubMed ID: 11865642
[TBL] [Abstract][Full Text] [Related]
31. [Myeloid crisis of chronic myelogenous leukemia showing dramatic response to mithramycin and hydroxyurea combination].
Ueki K; Tsuchida A; Murakami H; Karasawa M; Kobayashi N; Omine M; Naruse T
Rinsho Ketsueki; 1989 Oct; 30(10):1840-2. PubMed ID: 2531808
[TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase.
Meloni G; De Fabritiis P; Alimena G; Malagnino F; Montefusco E; Sandrelli A; Pinto R; Vignetti M; Lo Coco F; Mandelli F
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():92-4. PubMed ID: 2576389
[TBL] [Abstract][Full Text] [Related]
33. [Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy].
Sumi M; Tauchi T; Shimamoto T; Sshida G; Nakajima A; Ito Y; Ohyashiki K
Rinsho Ketsueki; 2002 Sep; 43(9):868-70. PubMed ID: 12412295
[TBL] [Abstract][Full Text] [Related]
34. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
35. [Hematologic response to low dose natural interferon-alpha in a case of CML with myelo-megakaryoblastic crisis].
Nozaki H; Usui T; Yamauchi K; Kobayashi N; Nakamura Y; Watanabe K; Nagao T; Arimori S
Rinsho Ketsueki; 1993 Feb; 34(2):232-4. PubMed ID: 8492424
[TBL] [Abstract][Full Text] [Related]
36. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; PodestĂ M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
37. High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia.
Mahon FX; Fabères C; Montastruc M; Si-Mour S; Boiron JM; Marit G; Bilhou-Nabera C; Cony-Makhoul P; Pigneux A; Bernard P; Broustet A; Reiffers J
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S33-7. PubMed ID: 8769698
[TBL] [Abstract][Full Text] [Related]
38. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
Goto H; Tsurumi H; Hara T; Moriwaki H
Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
[TBL] [Abstract][Full Text] [Related]
39. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
Katayama T; Masuoka H; Yoshida M; Watanabe R; Nishiwaki K; Shimada T; Kaito K; Ochiai S; Kobayashi M; Sakai O
Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
[TBL] [Abstract][Full Text] [Related]
40. [A case of chronic myelogenous leukemia complicated with nephrotic syndrome].
Yoshizaki N; Kohda K; Nakazawa O; Ando M; Miyazaki S; Takahashi M; Muramatsu H; Terada S; Kure T; Niitsu Y
Rinsho Ketsueki; 1989 May; 30(5):691-6. PubMed ID: 2529382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]